INB03 - Innate Immune System Checkpoint Inhibitor

INB03, is a first-in-class innate immune system check-point inhibitor that targets myeloid derived suppressor cells (MDSC), cells in the tumor microenvironment that produce an immunosuppressive shield that prevents the patient’s immune system from attacking the cancer.